Enke Bashllari is a trained neuroscientist who left academic research at Columbia University to become a venture capital investor, specifically to help translate brain and biology science into real-world medical advances rather than taking the typical finance or consulting path into VC. She focuses on investing in neurotech and AI-driven biology platforms during what she sees as a "now is possible" window created by recent advances at the intersection of hardware, software, and biology. Enke Bashllari is a trained neuroscientist who left academic research at Columbia University to become a venture capital investor, specifically to help translate brain and biology science into real-world medical advances rather than taking the typical finance or consulting path into VC. She focuses on investing in neurotech and AI-driven biology platforms during what she sees as a "now is possible" window created by recent advances at the intersection of hardware, software, and biology.